Obsidian Security Expands Go-to-Market Leadership Team to Scale SaaS Protection in the Age of AI
9.7.2025 15:00:00 CEST | Business Wire | Press Release
Obsidian Security, the leading SaaS security platform trusted by global enterprises including Snowflake, T-Mobile, and Pure Storage, today announced the expansion of its go-to-market leadership team with five strategic appointments. These hires position Obsidian to scale its operations as the company addresses the rapidly evolving security challenges posed by agentic AI and accelerates toward long-term growth and IPO readiness.
The company has appointed Alison Tierney as VP of Go-to-Market (GTM) Strategy, Corey Elinburg as Field Chief Technology Officer, Brian McHenry as Vice President (VP) of Worldwide Solutions Engineering, Tina Lei as VP of Revenue Marketing, and Tyler Mihevc to lead Mid-Market expansion. These appointments build upon Obsidian's recent hire of Chief Product Officer (CPO) Khanh Tran, former VP of Product Management at CrowdStrike, as the company assembles an industry-leading executive team. These leadership additions come as organizations worldwide grapple with unprecedented SaaS security risks driven by AI-powered attacks, application sprawl, embedded co-pilots, and AI agents leveraging overly permissive OAuth tokens.
“We’re proud to welcome leaders who have chosen Obsidian because they share in our mission and recognize the momentum we’ve built,” said Brian Murphy, Chief Revenue Officer of Obsidian Security. “Their confidence and expertise strengthen our ability to scale every part of our go-to-market engine—from engineering and sales to mid-market expansion and international strategy. As our customers face growing pressure to secure their SaaS environments while driving innovation, our success in meeting those demands depends on the strength of our team. This is a strategic inflection point, and we’re fully committed to increasing our market impact and driving long-term revenue growth.”
Addressing AI's Double-Edged Impact on SaaS Security
Agentic AI offers powerful productivity gains but also introduces new risks. While these agents streamline workflows and enhance efficiency, they expand the attack surface by leveraging the same integration mechanism used by SaaS-to-SaaS integrations. AI-embedded SaaS tools and autonomous systems operating with excessive permissions via longstanding OAuth connections magnify the SaaS-to-SaaS integration blindspot.
Obsidian's foundational Knowledge Graph provides a unique advantage in solving this problem. By unifying SaaS, endpoint, network, and identity data, Obsidian delivers the contextual insight necessary to understand not just what AI agents are accessing, but how that access fits within the broader ecosystem of application relationships and user behaviors.
The platform’s deep visibility into application usage—enriched with workload context and in-app activity monitoring—enables Obsidian to detect subtle OAuth token anomalies that signal malicious or compromised AI agents. This intimate understanding of SaaS interconnections is exactly what’s required to secure environments where autonomous agents have become new actors.
Building on this foundation, Obsidian is partnering with Fortune 500 customers to bring to market enterprise-tested solutions to safely and rapidly adopt Agentic AI.
Leadership Team Brings Proven Scale Experience
- Alison Tierney, VP of GTM Strategy, joins from Snowflake, where she served as SVP of Sales and VP of Global Sales Strategy, driving global expansion and scaling high-growth sales organizations. She also held sales leadership roles at AppDynamics and Oracle. At Obsidian, Tierney will focus on building unified go-to-market strategies and leading international expansion.
- Corey Elinburg, Field Chief Technology Officer, brings over 26 years of enterprise security leadership experience. Previously the Chief Information Security Officer (CISO) at CommonSpirit Health (parent organization of Dignity Health), Elinburg oversaw security and IT operations for more than 175,000 employees across 2,200+ care sites in 24 states. He brings invaluable perspective on securing large-scale, distributed organizations.
- Brian McHenry, VP of Worldwide Solutions Engineering, joins from F5, where he spent 16 years building and leading the global security practice for technical sales. He set global security sales strategy and played key roles in the $1B acquisition of Shape Security and $500M acquisition of Volterra. His deep experience scaling security solutions makes him well-positioned to lead Obsidian’s technical sales efforts globally.
- Tina Lei, VP of Revenue Marketing, brings extensive growth marketing expertise from NinjaOne, where she advanced from Performance Marketing Specialist to VP of Growth over nearly seven years. Lei led digital marketing, website optimization, and product-led growth, managing multi-million-dollar budgets and building high-performing teams.
- Tyler Mihevc leads Obsidian’s Mid-Market revenue team. He brings proven sales leadership from high-growth companies including Craft.co (Worldwide VP of Sales), PredictHQ (VP of Worldwide Sales and Customer Success), and senior roles at Okta. His appointment strengthens Obsidian’s ability to serve organizations navigating AI-integrated business environments.
Scaling for Long-Term Growth
Built by security leaders who previously redefined endpoint and identity security at CrowdStrike, Okta, Palo Alto Networks, and Cylance, Obsidian Security protects more than 200 organizations across North America, Europe, the Middle East, Southeast Asia, Australia, and New Zealand—including many of the world’s largest Fortune 1000 and Global 2000 companies.
The company secures business-critical SaaS applications such as Microsoft 365, Salesforce, and hundreds of other enterprise tools that drive modern work. Obsidian operates data centers in the US, Europe, the Middle East, and Australia to ensure robust protection for its global customer base. The company’s modular approach to SaaS security allows it to meet the needs of large and small enterprises.
“AI is changing the threat landscape faster than most organizations can respond,” said Hasan Imam, CEO of Obsidian Security. “This moment demands leadership that understands both the scale of the challenge and the urgency of the opportunity. We’re building a team that’s done this before—so we can stay ahead of emerging threats and deliver on the promise of safe, scalable AI adoption.”
About Obsidian Security
Obsidian Security is the leading SaaS security platform, trusted by global enterprises like Snowflake, T-Mobile, and Pure Storage. We protect over 200 global organizations, including many of the world’s largest Fortune 1000 and Global 2000 companies with data center availability in North America, EMEA, and APAC. Backed by top investors like Greylock, we’re closing a critical gap: securing the SaaS apps where business happens like Microsoft 365, Salesforce, and hundreds more. Our platform reduces risk, detects and responds to threats, and prevents breaches at the source. Obsidian was built by leaders who redefined endpoint and identity security at CrowdStrike, Okta, Cylance, and Carbon Black. Now, we’re tackling the next frontier: securing SaaS in the era of agentic AI. As AI tools gain access to sensitive data through integrations, Obsidian uniquely detects human and non-human identity compromise and manages integration risk.
For more information, visit www.obsidiansecurity.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250709964755/en/
Contacts
Media Contact
Sean Roche
Product Marketing, Obsidian Security
sroche@obsidiansecurity.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom